<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100022'>Movement disorders</z:hpo> have only rarely been reported in association with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="1" pm="."><plain>In such cases, <z:hpo ids='HP_0002072'>chorea</z:hpo> is the most common disorder observed, with occasional reports of hemidystonia, <z:hpo ids='HP_0001300'>Parkinsonism</z:hpo>, and hemiballism </plain></SENT>
<SENT sid="2" pm="."><plain>We report here on 3 cases of APS (3 women ages 16, 46, and 56 years) who presented with <z:hpo ids='HP_0100022'>movement disorders</z:hpo>, including <z:hpo ids='HP_0100033'>tics</z:hpo>, <z:hpo ids='HP_0001337'>tremor</z:hpo>, <z:hpo ids='HP_0001336'>myoclonus</z:hpo>, and a corticobasal syndrome, never or rarely reported in association with this disease </plain></SENT>
<SENT sid="3" pm="."><plain>Mild executive dysfunction was observed in <z:hpo ids='HP_0000001'>all</z:hpo> 3 patients </plain></SENT>
<SENT sid="4" pm="."><plain>We also report the successful treatment of two of these patients with mild oral anticoagulation (INR 2-3) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0100022'>Movement disorders</z:hpo> in APS seem more clinically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> than previously thought </plain></SENT>
<SENT sid="6" pm="."><plain>Oral anticoagulation should be considered in the treatment of <z:hpo ids='HP_0100022'>movement disorders</z:hpo> associated with APS </plain></SENT>
</text></document>